EPITHELIAL TUMOR MARKERS (CA 125, CA 19-9 AND CEA) TRENDS IN PATIENTS UNDERGOING TREATMENT FOR INVASIVE BLADDER CANCER

被引：0
|
作者：
Bazargani, Soroush T.
Shah, Swar
Ahmadi, Hamed
Schuckman, Anne
Cai, Jie
Miranda, Gus
Dorff, Tanya
Sadeghi, Sarmad
Quinn, David
Djaladat, Hooman
Daneshmand, Siamak
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD23-09
引用
收藏
页码：E483 / E484
页数：2
相关论文
共 50 条
  • [21] CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis
    Björnsson, E
    Kilander, A
    Olsson, R
    LIVER, 1999, 19 (06): : 501 - 508
  • [22] CEA and CA 19-9 as prognostic indexes in colorectal cancer
    Forones, NM
    Tanaka, M
    HEPATO-GASTROENTEROLOGY, 1999, 46 (26) : 905 - 908
  • [23] Clinical role of serum tumor markers SCC, NSE, CA 125, CA 19-9, and CYFRA 21-1 in patients with lung cancer
    Sun, Aiwen
    LABORATORY MEDICINE, 2023, 54 (06) : 638 - 645
  • [24] EVALUATION OF TUMOR-MARKERS CA19-9, CA125 AND CEA IN PANCREATIC-CANCER AND OTHER DISEASES
    ZHANG, HY
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 522 - 522
  • [25] The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3
    Bassi, C
    Salvia, R
    Gumbs, AA
    Butturini, G
    Falconi, M
    Pederzoli, P
    LANGENBECKS ARCHIVES OF SURGERY, 2002, 387 (7-8) : 281 - 285
  • [26] The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3
    Claudio Bassi
    Roberto Salvia
    Andrew A. Gumbs
    Giovanni Butturini
    Massimo Falconi
    Paolo Pederzoli
    Langenbeck's Archives of Surgery, 2002, 387 : 281 - 285
  • [27] The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis
    Schöniger-Hekele, M
    Müller, C
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (02) : 338 - 345
  • [28] ASSESSMENT OF SERUM CA 19-9 LEVELS AS A TUMOR MARKER IN PATIENTS WITH BLADDER TUMOR
    Kosan, Murat
    Tul, Mesut
    Ugurlu, Ozgur
    Gonulalan, Umut
    Ozturk, Bulent
    Adsan, Oztug
    TURKISH JOURNAL OF UROLOGY, 2005, 31 (03): : 342 - 348
  • [29] The Combined Elevation of Tumor Markers CA 19-9 and CA 125 in Liver Disease Patients Is Highly Specific for Severe Liver Fibrosis
    Maximilian Schöniger-Hekele
    Christian Müller
    Digestive Diseases and Sciences, 2006, 51 : 338 - 345
  • [30] EFFICACY OF CARBOHYDRATE ANTIGENS (CA 19-9, CA 125, CA 15-3) FOR DIAGNOSIS AND PROGNOSTIC FACTORS OF BLADDER TUMOR
    Kosan, Murat
    Tul, Mesut
    Gonulalan, Umut
    Ugurlu, Ozgur
    Inal, Gurdal
    Adsan, Oztug
    TURKISH JOURNAL OF UROLOGY, 2008, 34 (02): : 155 - 160
12345